Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.
about
ABO-Mismatched Allogeneic Hematopoietic Stem Cell TransplantationGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantationWhat would Karl Landsteiner do? The ABO blood group and stem cell transplantation.Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.Non-myeloablative allogeneic hematopoietic stem cell transplantation.Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.Transfusion support issues in hematopoietic stem cell transplantation.The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor.Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility.Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.IgM anti-recipient ABO antibodies predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.Successful management of sudden, massive immune hemolysis following ABO-incompatible allogeneic PBSCT despite methotrexate GvHD prophylaxis.Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation.Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT.Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.Massive immune hemolysis caused by anti-D after dual kidney transplantation.Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation.Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation.
P2860
Q26750395-F70413EE-652C-4045-992D-65F43EEF4209Q30276550-629D546A-C0DB-4CA0-9FFA-2DCF4F7135BAQ34122035-AE5FBA3A-513B-4161-98BE-FE4230C1F2D7Q35187185-D6895111-E9F3-47FD-B13F-D982CC59C7D3Q36207276-D31D2157-6361-499A-B663-4DE5ABBB50A5Q36266359-0E273637-31E2-457C-A30A-DFD925601C71Q37308127-4F60A27B-3840-49E0-A840-2DCC02D8B029Q37928443-0D35943E-8B30-4BF6-9A2C-2A9C6D62BA1FQ38287605-1B2DB193-9975-4FE1-8BB6-A3150FA34C8BQ40359224-A6754FF5-2A37-44DB-BA5A-38AE7AA36EB2Q43703956-904247C5-D6B9-4A4D-9F79-6646B515B363Q44051851-37B21511-AF92-4D77-B4F0-1843133E367EQ44398792-BC1B5319-8122-4C02-A6DF-2E8AE3D357B4Q45172618-E562E1AB-75A2-4A0C-9AC2-6D95A44A6D84Q45839863-AB3323E4-2ED8-41D1-A60E-06B83D97E867Q46168868-908E8652-34D7-4801-8341-146004AF1B0FQ46772665-87B71B8B-EF12-4048-8CBE-45A0C103C53DQ47431505-6B50C610-42B8-4612-BC47-B7C5DBA941CAQ47575405-CE245CA3-0114-46D2-B3C1-4DFC524069DAQ47752542-2E66E2D7-4FEF-4985-885B-7630DB430009Q50225112-5B673606-884E-49C9-BBF6-2375DBAADAE3Q50448290-603EDCDF-E3EC-47E5-951A-6643180BA92AQ50686421-71AAD06D-AAB5-4214-9B72-B99389ACCCE2Q50755086-74DC6853-F100-4D24-8269-C719BEC76560Q50777049-745A09B2-2E52-4D9A-9A58-38131B32E618Q53619723-B8E34F38-ECFB-4A21-8419-8DAF98C6D84CQ53658801-3C2E9263-C586-4C5A-B6D2-307D9415FD57
P2860
Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Massive immune haemolysis afte ...... ith minor ABO incompatibility.
@en
Massive immune haemolysis afte ...... ith minor ABO incompatibility.
@nl
type
label
Massive immune haemolysis afte ...... ith minor ABO incompatibility.
@en
Massive immune haemolysis afte ...... ith minor ABO incompatibility.
@nl
prefLabel
Massive immune haemolysis afte ...... ith minor ABO incompatibility.
@en
Massive immune haemolysis afte ...... ith minor ABO incompatibility.
@nl
P2093
P2860
P1476
Massive immune haemolysis afte ...... ith minor ABO incompatibility.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.2001.02587.X
P407
P577
2001-03-01T00:00:00Z